VAPOTHERM, INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1999-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.vapotherm.com
Clinical Trials
10
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Effect of High Velocity/Hyperoxic Breathing Therapy on Blood Lactate Decline
- Conditions
- BreathlessnessExerciseMuscleRecoveryDyspneaLactic Acidosis
- First Posted Date
- 2023-08-09
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Vapotherm, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT05984186
- Locations
- 🇺🇸
Auburn University, Auburn, Alabama, United States
Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants
- Conditions
- Neonatal Respiratory DistressOxygen SaturationInfant, PrematureBronchopulmonary Dysplasia
- First Posted Date
- 2021-09-01
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Vapotherm, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT05030012
- Locations
- 🇺🇸
Children's National Hospital & Research Institute, Washington, District of Columbia, United States
🇺🇸University of Utah Hospital, Salt Lake City, Utah, United States
🇺🇸Seattle Children's Hospital, Seattle, Washington, United States
Clinical Stabilization of Hypercapnia: NIPPV v HVNI
- Conditions
- DyspneaHypercapnic AcidosisHypercapnic Respiratory FailureChronic Obstructive Pulmonary Disease
- First Posted Date
- 2021-01-14
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Vapotherm, Inc.
- Target Recruit Count
- 68
- Registration Number
- NCT04709562
- Locations
- 🇺🇸
Valley Presbyterian Hospital, Los Angeles, California, United States
🇺🇸Dignity Health - St. John's Regional Medical Center, Oxnard, California, United States
🇺🇸George Washington University Hospital, Washington, District of Columbia, United States
Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Device Equivalence
- Conditions
- HypercapniaRespiratory InsufficiencyDyspnea
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Vapotherm, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT04590014
- Locations
- 🇺🇸
VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States
Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Cannulae Designs
- Conditions
- HypercapniaDyspneaRespiratory Insufficiency
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Vapotherm, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT04512781
- Locations
- 🇺🇸
VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States
🇺🇸Erlanger Baroness Hospital, Chattanooga, Tennessee, United States
- Prev
- 1
- 2
- Next